Why NeuroMetrix (NURO) Stock Is Soaring Today

NEW YORK (TheStreet) -- NeuroMetrix  (NURO) soared Tuesday after the FDA cleared the medical device company's wearable technology for over-the-counter use in treating chronic pain.

The FDA granted 501(k) clearance for the device, which is in late-stage development. It uses electrical stimulation of sensory nerves to relieve pain. The company said in a statement the technology is lightweight and can be worn during the day and while sleeping. 

NeuroMetrix expects to release the product in 2015.

Must Read:
Warren Buffett's 25 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

The stock was up 39.15% to $2.63 at 10:13 a.m. More than 4.3 million shares changed hands, compared to the average volume of 122,471.

NURO Chart

NURO data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

Global Stocks Hit by Asia Tech Weakness, Oil Price Rally; U.S. Futures Slip

Global Stocks Hit by Asia Tech Weakness, Oil Price Rally; U.S. Futures Slip

Skechers Slumps in Pre-Market After Soft Guidance Overshadows Solid Q1

Skechers Slumps in Pre-Market After Soft Guidance Overshadows Solid Q1

Ericsson Rockets After Solid Q1 Following Cevian Push to Accelerate Turnaround

Ericsson Rockets After Solid Q1 Following Cevian Push to Accelerate Turnaround

P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI

P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?